PET Imaging Agents (FDG) (Vincent Bouvet)

In this focused session from the CANM’25 Radiopharmacy Review Course, Vincent Bouvet presents an overview of FDG PET imaging agents and their central role in nuclear medicine. The lecture reviews the preparation, quality considerations, and clinical relevance of fluorodeoxyglucose (FDG), one of the most widely used PET radiopharmaceuticals. Emphasis is placed on how FDG supports molecular imaging across oncology, neurology, cardiology, and infection/inflammation applications. This session is part of the 2025 CANM Radiopharmacy Review Course, a comprehensive program designed to provide an overview of the preparation of SPECT, PET, and therapeutic radiopharmaceuticals, including radionuclide production, quality control, and regulatory considerations. Developed under the direction of Dr. Freimut Juengling, Dr. Jan Andersson, Dr. Andrew Ross, and Dr. Svetlana Selivanova, the course offers a concise yet comprehensive framework for professionals seeking to strengthen their expertise in radiopharmacy and molecular imaging. #Radiopharmacy #FDG #PETImaging #NuclearMedicine #MolecularImaging #CANM2025